🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12554+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12554 recruiting trials

NARecruitingNCT05942248

The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis

👨‍⚕️ Raja Sivamani, MD, MS, AP, Integrative Skin and Research📍 1 site📅 Started Jun 2023View details ↗
NARecruitingNCT06666881

Skeletal Muscle Mass Changes on Images for Prediction of Prognosis After Exercise Training in HNSCC Patients

👨‍⚕️ Shao-Chung Wang, New Taipei City TuCheng Hospital📍 1 site📅 Started Jun 2023View details ↗
Phase 2, PHASE3RecruitingNCT06125327

SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

🏥 Guangzhou JOYO Pharma Co., Ltd📍 1 site📅 Started Jun 2023View details ↗
NARecruitingNCT05833217

Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2

👨‍⚕️ Tracey McLaughlin, MD, Stanford School of Medicine📍 2 sites📅 Started Jun 2023View details ↗
RecruitingNCT05810480

PredIcting SterOid DepeNdEnt LivEr InjuRy with Polyreactive Immunoglobulin G

👨‍⚕️ Bastian Engel, Dr., Hannover Medical School📍 8 sites📅 Started Jun 2023View details ↗
RecruitingNCT05991336

Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy

🏥 Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Jun 2023View details ↗
Phase 1, PHASE2RecruitingNCT05908409

A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies

👨‍⚕️ Enrique Ocio San Miguel, MD, PhD, Hospital Universitario Marqués de Valdecilla📍 11 sites📅 Started Jun 2023View details ↗
NARecruitingNCT05867940

Effects of Physical Activity on Prescription (PAP) as a Health-enhancing Intervention in People With Disabilities

👨‍⚕️ Katarina Lauruschkus, PhD, Region Skåne Sweden📍 1 site📅 Started Jun 2023View details ↗
Phase 3RecruitingNCT05303519

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

🏥 Nuvation Bio Inc.📍 45 sites📅 Started Jun 2023View details ↗
RecruitingNCT05942456

Soluble B7-H3 as a Biomarker for Osteosarcoma

🏥 Peking University People's Hospital📍 1 site📅 Started Jun 2023View details ↗
Phase 2Enrolling by InvitationNCT05957913

Effects of Antiviral Therapies on Epstein-Barr Virus Replication

👨‍⚕️ Michael Levy, MD, PhD, Massachusetts General Hospital📍 1 site📅 Started Jun 2023View details ↗
NARecruitingNCT05872737

FAB Programme for Parents of Children With NDD

🏥 Chinese University of Hong Kong📍 2 sites📅 Started Jun 2023View details ↗
RecruitingNCT06203652

The Pathogenesis and Prognostic Factors of Lymphoma

🏥 Shanghai Zhongshan Hospital📍 1 site📅 Started Jun 2023View details ↗
Phase 1RecruitingNCT05762419

FUS Etoposide for DMG

👨‍⚕️ Stergios Zacharoulis, MD, Columbia University📍 1 site📅 Started Jun 2023View details ↗
NARecruitingNCT04762134

Doxycycline Intervention for Bacterial STI ChemoprOphylaxis (DISCO)

👨‍⚕️ Troy Grennan, MD, University of British Columbia📍 6 sites📅 Started Jun 2023View details ↗
Phase 2RecruitingNCT05681039

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

👨‍⚕️ Luana Guimaraes De Sousa, MD PhD, M.D. Anderson Cancer Center📍 1 site📅 Started Jun 2023View details ↗
Phase 2RecruitingNCT05868265

A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

👨‍⚕️ Scot Niglio, MD, MS, Memorial Sloan Kettering Cancer Center📍 8 sites📅 Started Jun 2023View details ↗
RecruitingNCT05902416

Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome

🏥 Peking University People's Hospital📍 1 site📅 Started Jun 2023View details ↗
RecruitingNCT05844579

The ICU LIBERATION Study

🏥 Japanese Society for Early Mobilization📍 1 site📅 Started Jun 2023View details ↗
RecruitingNCT05898932

Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes

👨‍⚕️ James W. Griffith, PhD, University of Chicago📍 1 site📅 Started Jun 2023View details ↗
← PreviousPage 402 of 628Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →